APAC Peripheral Intravenous Catheters Market

The size of the Asia Pacific Peripheral Intravenous Catheters Market was around USD 0.60 Billion in 2022. It is expected to grow at a CAGR of 6.7% to reach USD 0.83 billion by 2027. It captures 20% of the global market.

A peripheral intravenous catheter is a tiny tube inserted into a vein and used to inject medicine directly into the bloodstream. Modern peripheral intravenous (IV) catheters have additional safety features to prevent needlestick injuries. The increasing adoption of these devices in emerging nations and the increased focus on preventing needle-stick injuries and high healthcare spending are expected to drive significant growth.

The rising popularity of integrated/closed peripheral intravenous catheters among the people in APAC is likely to fuel the growth of the peripheral intravenous (IV) catheter market. However, the rising prevalence of disease and infection is one of the other key factors driving the demand for catheterization in hospitals, healthcare centers, ambulatory surgery centers, clinics, and home healthcare units. 

The rising frequency of disease outbreaks is expected to significantly increase the demand for peripheral intravenous catheters for patient evaluation, diagnosis, and treatment. Compared to other catheters, this is expected to include a higher percentage of PIVCs. Most importantly, higher healthcare spending and improvements in healthcare infrastructure will continue to support market growth. Furthermore, the introduction of PIVC technology will enhance sales even more.

The rising ability to afford expensive medical treatments, such as catheterization, continues to be a significant driver of market growth. The PIVC is regarded perfect for convenient, direct delivery of antibiotics, IVs, analgesics, and psycoleptics, among other things. In addition, it is essential in the prevention of blood-borne pathogen infections. These characteristics are currently driving the peripheral intravenous catheter market in the Asia Pacific.

However, the high cost of peripheral intravenous catheters and various complications associated with peripheral intravenous catheters are expected to restrain the growth of the peripheral intravenous catheter market. In contrast, a lack of training for the use of peripheral catheters, as well as painful insertion, is also expected to limit the market's growth. In addition, unaffordable catheterization procedures may stymie PIVC adoption in Asia Pacific's growing markets. Due to stringent regulatory requirements relating to medical devices in some locations, traditional PIVC sales are projected to decline significantly.

The APAC Peripheral Intravenous Catheters Market has been segmented and sub-segmented into the following categories:

• By Product: Short PIVC (Ported Peripheral Intravenous Catheter and Non-ported Peripheral Intravenous Catheter) and Integrated/Closed PIVC   
• By Type: Integrated/Closed catheters and Peripheral insertion catheters     
• By End User: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs), Home Use and Others   
• By Technology: Conventional Peripheral Intravenous Catheter and Safety Peripheral Intravenous Catheter
• By Country: India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore, and the Rest of APAC

Geographically, Asia-Pacific is the fastest-growing market because of the rapidly improving healthcare infrastructure, rising disposable income, and rapidly growing medical tourism industry. Additionally, India and China have the largest population pool in the world. Thus the large senior population of both countries will lead to an increasing patient population in the near future.

KEY MARKET PLAYERS:

Companies dominating the market include Smith Medical, Terumo Corporation, C. R. Bard, Inc., Becton Dickinson and Company, B. Braun Melsungen AG, Tangent Medical, and Vygon Group.